HCi Viocare Announces Corporate Mandate to Raise up to 30 Million Euro

HCi Viocare announced its board of directors has agreed to source up to EUR 30 million in funding. Proceeds from the financing will be used for marketing its patent pending 'smart insole', the development of its other Smart Medical solutions, for general operating capital, as well as the expansion of its proposed chain of independent prosthetics and orthotics (P&O) and diabetic foot clinics.

"The financing will be instrumental in moving the Company forward in the Smart Medical field as well as expanding our base of prosthetic, orthotic and diabetic foot clinics," stated Sotiris Leontaritis, CEO and President of HCi Viocare.